ArticlePharmaceutics2025

Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3.

Hoang Lan Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.